155 related articles for article (PubMed ID: 30378118)
1. Formulation and evaluation of anticancer and antiangiogenesis efficiency of PLA-PEG nanoparticles loaded with galbanic acid in C26 colon carcinoma, in vitro and in vivo.
Afsharzadeh M; Abnous K; Yazdian-Robati R; Ataranzadeh A; Ramezani M; Hashemi M
J Cell Physiol; 2019 May; 234(5):6099-6107. PubMed ID: 30378118
[TBL] [Abstract][Full Text] [Related]
2. PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells.
Afsharzadeh M; Hashemi M; Babaei M; Abnous K; Ramezani M
J Cell Physiol; 2020 May; 235(5):4618-4630. PubMed ID: 31674023
[TBL] [Abstract][Full Text] [Related]
3. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
4. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
5. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.
Essa S; Rabanel JM; Hildgen P
Eur J Pharm Biopharm; 2010 Jun; 75(2):96-106. PubMed ID: 20211727
[TBL] [Abstract][Full Text] [Related]
6. Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma.
Nik ME; Malaekeh-Nikouei B; Amin M; Hatamipour M; Teymouri M; Sadeghnia HR; Iranshahi M; Jaafari MR
Sci Rep; 2019 Jul; 9(1):9527. PubMed ID: 31267009
[TBL] [Abstract][Full Text] [Related]
7. Formulation, characterization, and geno/cytotoxicity studies of galbanic acid-loaded solid lipid nanoparticles.
Eskandani M; Barar J; Dolatabadi JE; Hamishehkar H; Nazemiyeh H
Pharm Biol; 2015; 53(10):1525-38. PubMed ID: 25853953
[TBL] [Abstract][Full Text] [Related]
8. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
[TBL] [Abstract][Full Text] [Related]
9. Poly(d,l-lactide)/polyethylene glycol micro/nanofiber mats as paclitaxel-eluting carriers: preparation and characterization of fibers, in vitro drug release, antiangiogenic activity and tumor recurrence prevention.
Hobzova R; Hampejsova Z; Cerna T; Hrabeta J; Venclikova K; Jedelska J; Bakowsky U; Bosakova Z; Lhotka M; Vaculin S; Franek M; Steinhart M; Kovarova J; Michalek J; Sirc J
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():982-993. PubMed ID: 30813105
[TBL] [Abstract][Full Text] [Related]
10. Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(d,l-lactide) (PLA) based nanoparticles.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2010 Mar; 388(1-2):263-73. PubMed ID: 20060450
[TBL] [Abstract][Full Text] [Related]
11. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
Gan CW; Feng SS
Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
[TBL] [Abstract][Full Text] [Related]
12. Gambogic acid-loaded PEG-PCL nanoparticles act as an effective antitumor agent against gastric cancer.
Zhang D; Zou Z; Ren W; Qian H; Cheng Q; Ji L; Liu B; Liu Q
Pharm Dev Technol; 2018 Jan; 23(1):33-40. PubMed ID: 29069711
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery.
Liu D; Wang L; Liu Z; Zhang C; Zhang N
J Biomed Nanotechnol; 2010 Dec; 6(6):675-82. PubMed ID: 21361132
[TBL] [Abstract][Full Text] [Related]
14. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
Sant S; Poulin S; Hildgen P
J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
[TBL] [Abstract][Full Text] [Related]
15. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
17. PEGylated solid lipid nanoparticles functionalized by aptamer for targeted delivery of docetaxel in mice bearing C26 tumor.
Shakib Z; Mahmoudi A; Moosavian SA; Malaekeh-Nikouei B
Drug Dev Ind Pharm; 2022 Feb; 48(2):69-78. PubMed ID: 35758194
[TBL] [Abstract][Full Text] [Related]
18. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
19. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
[TBL] [Abstract][Full Text] [Related]
20. Novel nano-vehicle for delivery and efficiency of anticancer auraptene against colon cancer cells.
Jalilzadeh N; Samadi N; Salehi R; Dehghan G; Iranshahi M; Dadpour MR; Hamishehkar H
Sci Rep; 2020 Jan; 10(1):1606. PubMed ID: 32005894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
